Exelixis
EXEL
#1580
Rank
NZ$19.21 B
Marketcap
$68.66
Share price
-0.36%
Change (1 day)
85.84%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company